ZNF217 gene has been extensively studied in breast cancer [4, 17], ovarian cancer [18, 19, 20], esophageal squamous cell carcinoma [21], gastric cancer [22, 23, 24] and prostate cancer [25, 26], but not in CRC. This evidence concerns the gene ZNF217 and ovarian carcinoma.